Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

27.70 

0.17 0.6%

as of Jun 13 '19

52 Week Range:

22.91 29.70


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Unicharm Corporation manufactures and sells baby and child care, feminine care, healthcare, cosmetic, household, and pet care products in Japan and internationally. Its baby and child care products, including disposable diapers, swimming and training pants, night time pants, wet tissues, and wipes under the Moony and MamyPoko brands; and feminine care products comprise feminine napkins, tampons, sanitary shorts, panty liners, and other feminine care products under the Sofy, Center-In, and Unicharm brands. The company's health care products include napkin-type incontinence pads, pants-type diapers, tape-type diapers, pants-type specialized urine pads, and tape-type specialized urine pads under the Lifree brand. It also provides home care products, including cleaning sheets under the Wave brand; personal care products, such as cosmetic puffs and wet tissues under the Silcot brand; and kitchen care products comprising paper towels under the Cook Up brand. In addition, the company offers pet care products that include pet foods, excrement cleanup sheets, system toilets, and disposable diapers under the Aiken Genki, Neko Genki, Gaines, Gin no Spoon, and Gin no Sara brands. Further, it manufactures and sells industrial materials, food-packaging materials, etc.; urinary products, such as gentle skin type and pantiliner type products, pants, napkins, men's incontinence pads, and slight leakage pads; nursing care products, such as tape type incontinence pad, pants type, and adult care products; and masks. The company was founded in 1961 and is headquartered in Tokyo, Japan.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Mar '09 Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 4.78
4.84
4.76
5.87
growth rate 1.3% -1.7% 23.3%
Earnings BIT 67,241.00
81,797.31
79,936.00
79,116.00
86,839.00
94,950.00
growth rate 21.7% -2.3% -1.0% 9.8% 9.3%
Avg.PE 33.58
34.73
26.99
33.44
growth rate 3.4% -22.3% 23.9%
ROA 6.19
8.35
8.93
5.89
8.56
6.61
5.77
6.24
7.29
8.01
growth rate 34.9% 7.0% -34.0% 45.3% -22.8% -6.6% 8.2% 16.8% 9.9%
ROE 10.38
13.92
17.38
12.96
17.10
11.50
10.46
11.39
13.61
14.80
growth rate 34.1% 24.9% -25.4% 31.9% -32.8% -4.6% 8.9% 19.5% 8.7%
ROIC 9.87
13.29
12.57
7.92
11.99
9.69
8.71
9.29
10.68
13.30
growth rate 34.7% -5.4% -37.0% 51.4% -19.2% -5.2% 6.7% 15.0% 24.5%
Cur. Ratio 1.92
1.87
2.27
1.79
1.73
1.78
1.97
2.00
2.10
1.66
growth rate -2.6% 21.4% -21.2% -3.4% 2.9% 5.2% 1.5% 5.0% -21.0%
Quick Ratio 1.50
1.55
1.83
1.29
1.20
1.21
1.39
1.50
1.69
1.25
growth rate 3.3% 18.1% -29.5% -7.0% 0.8% 7.2% 7.9% 12.7% -26.0%
Leverage 1.66
1.67
2.20
2.21
1.84
1.66
1.81
1.84
1.90
1.80
growth rate 0.6% 31.7% 0.5% -16.7% -9.8% 4.4% 1.7% 3.3% -5.3%
Balance Sheet Mar '09 Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 60,264.00
67,597.00
88,442.00
95,328.00
90,637.00
98,821.00
100,159.00
growth rate 12.2% 30.8% 7.8% -4.9% 9.0% 1.4%
Acct.Payable 53,185.00
78,433.00
91,586.00
93,799.00
93,257.00
98,295.00
153,494.00
growth rate 47.5% 16.8% 2.4% -0.6% 5.4% 56.2%
Cur.Assets 210,728.00
265,191.00
321,772.00
331,693.00
339,637.00
407,176.00
384,441.00
growth rate 25.9% 21.3% 3.1% 2.4% 19.9% -5.6%
Total Assets 535,055.00
620,419.00
699,108.00
702,601.00
668,592.00
736,644.00
795,483.00
growth rate 16.0% 12.7% 0.5% -4.8% 10.2% 8.0%
Cash 74,321.00
108,901.00
138,781.00
138,503.00
138,043.00
169,903.00
135,065.00
growth rate 46.5% 27.4% -0.2% -0.3% 23.1% -20.5%
Inventory 44,784.00
51,627.00
62,432.00
64,028.00
57,403.00
60,529.00
71,939.00
growth rate 15.3% 20.9% 2.6% -10.4% 5.5% 18.9%
Cur.Liabilities 121,547.00
148,903.00
190,183.00
168,630.00
176,962.00
193,979.00
231,498.00
growth rate 22.5% 27.7% -11.3% 4.9% 9.6% 19.3%
Liabilities 205,856.00
188,270.00
206,266.00
251,512.00
254,205.00
283,616.00
291,813.00
growth rate -8.5% 9.6% 21.9% 1.1% 11.6% 2.9%
LT Debt 76,333.00
21,000.00
5,420.00
65,178.00
61,190.00
58,000.00
21,428.00
growth rate -72.5% -74.2% 1,102.6% -6.1% -5.2% -63.1%
Equity 374,430.00
419,890.00
387,470.00
352,098.00
387,567.00
441,456.00
growth rate 12.1% -7.7% -9.1% 10.1% 13.9%
Common Shares 575.00
571.00
598.00
622.00
617.00
612.00
15,992.00
609.00
615.00
608.00
606.00
growth rate -0.7% 4.7% 4.0% -0.8% -0.8% 2,513.1% -96.2% 1.0% -1.1% -0.3%
Cash Flow Statement Mar '09 Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 47,875.00
58,738.00
56,403.99
46,575.00
37,862.00
32,598.00
43,303.00
growth rate 22.7% -4.0% -17.4% -18.7% -13.9% 32.8%
Cash Dividends 6,849.00
10,445.33
8,284.00
9,173.00
9,986.00
13,592.00
growth rate 52.5% -20.7% 10.7% 8.9% 36.1%
Cash From OA 68,758.00
95,659.00
91,855.98
85,009.00
103,604.00
98,086.00
110,867.00
growth rate 39.1% -4.0% -7.5% 21.9% -5.3% 13.0%
FCF per Share 0.46
0.63
0.78
0.95
growth rate 37.0% 23.8% 21.8%
Sale Purchase of Stock 2,443.00
489.33
427.00
950.00
growth rate -80.0% -12.7% 122.5%
FCF 7,188.00
30,595.00
-45,059.00
32,949.00
20,047.00
35,734.00
35,451.99
38,434.00
65,743.00
65,488.00
67,564.00
growth rate 325.6% -100.0% 100.0% -39.2% 78.3% -0.8% 8.4% 71.1% -0.4% 3.2%
Income Statement Mar '09 Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 495,771.00
599,455.00
738,214.48
738,707.00
604,653.00
641,647.00
688,290.00
growth rate 20.9% 23.2% 0.1% -18.2% 6.1% 7.3%
Op.Income 48,911.00
67,241.00
81,797.31
79,936.00
79,116.00
86,839.00
94,950.00
growth rate 37.5% 21.7% -2.3% -1.0% 9.8% 9.3%
IBT 67,901.00
93,367.98
77,339.00
75,836.00
92,927.00
91,561.00
growth rate 37.5% -17.2% -1.9% 22.5% -1.5%
Net Income 48,911.00
38,216.00
43,641.32
40,511.00
46,971.00
52,772.00
61,353.00
growth rate -21.9% 14.2% -7.2% 16.0% 12.4% 16.3%
EPS 29.80
128.55
56.14
43.35
69.85
62.40
66.51
76.63
87.06
101.44
growth rate 331.4% -56.3% -22.8% 61.1% -10.7% 3.2% 15.2% 13.6% 16.5%
Gross Profit 227,028.00
267,648.00
326,986.58
332,186.00
227,811.00
248,546.00
265,285.00
growth rate 17.9% 22.2% 1.6% -31.4% 9.1% 6.7%
R&D 6,071.00
6,071.00
6,071.00
6,554.00
6,621.00
growth rate 0.0% 0.0% 8.0% 1.0%

Quarterly Statements

Item Name Mar '18 Jun '18 Sep '18 Dec '18 Mar '19
Earnings BIT 25,318.00
22,452.00
27,958.00
19,223.00
20,812.00
growth rate -11.3% 24.5% -31.2% 8.3%
Balance Sheet Mar '18 Jun '18 Sep '18 Dec '18 Mar '19
Acct.Receivable 84,043.00
80,376.00
98,708.00
100,159.00
95,204.00
growth rate -4.4% 22.8% 1.5% -5.0%
Acct.Payable 130,335.00
133,379.00
145,657.00
153,494.00
139,728.00
growth rate 2.3% 9.2% 5.4% -9.0%
Cur.Assets 389,810.00
400,297.00
379,367.00
384,441.00
366,752.00
growth rate 2.7% -5.2% 1.3% -4.6%
Total Assets 721,093.00
739,448.00
788,950.00
795,483.00
814,721.00
growth rate 2.6% 6.7% 0.8% 2.4%
Cash 166,034.00
183,968.00
129,393.00
135,065.00
108,705.00
growth rate 10.8% -29.7% 4.4% -19.5%
Inventory 61,043.00
63,921.00
73,804.00
71,939.00
72,354.00
growth rate 4.7% 15.5% -2.5% 0.6%
Cur.Liabilities 177,479.00
189,176.00
215,316.00
231,498.00
208,371.00
growth rate 6.6% 13.8% 7.5% -10.0%
Liabilities 266,682.00
254,501.00
281,756.00
291,813.00
302,357.00
growth rate -4.6% 10.7% 3.6% 3.6%
LT Debt 56,553.00
34,192.00
33,294.00
21,428.00
16,903.00
growth rate -39.5% -2.6% -35.6% -21.1%
Equity 387,572.00
424,976.00
444,206.00
441,456.00
447,309.00
growth rate 9.7% 4.5% -0.6% 1.3%
Common Shares 15,993.00
15,993.00
15,993.00
15,993.00
15,993.00
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Mar '18 Jun '18 Sep '18 Dec '18 Mar '19
Capital Expenditures 6,854.00
15,396.00
13,449.00
7,604.00
11,500.00
growth rate 124.6% -12.7% -43.5% 51.2%
Cash Dividends 6,449.00
7,196.00
7,196.00
7,167.00
7,167.00
growth rate 11.6% 0.0% -0.4% 0.0%
Cash From OA 22,677.00
35,245.00
21,642.00
31,303.00
6,129.00
growth rate 55.4% -38.6% 44.6% -80.4%
FCF 15,823.00
19,849.00
8,193.00
23,699.00
-5,371.00
growth rate 25.4% -58.7% 189.3% -100.0%
Income Statement Mar '18 Jun '18 Sep '18 Dec '18 Mar '19
Sales 160,936.00
164,749.00
172,430.00
190,175.00
168,611.00
growth rate 2.4% 4.7% 10.3% -11.3%
Op.Income 25,318.00
22,452.00
27,958.00
19,223.00
20,812.00
growth rate -11.3% 24.5% -31.2% 8.3%
IBT 21,824.00
23,594.00
28,487.00
17,656.00
20,940.00
growth rate 8.1% 20.7% -38.0% 18.6%
Net Income 14,178.00
15,823.00
17,085.00
14,267.00
12,701.00
growth rate 11.6% 8.0% -16.5% -11.0%
Gross Profit 62,799.00
64,052.00
68,149.00
70,285.00
60,924.00
growth rate 2.0% 6.4% 3.1% -13.3%
R&D 6,621.00
6,621.00
6,621.00
6,621.00
growth rate 0.0% 0.0% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (64.62)

YOY Growth Grade:

D (42.33)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 32.81 32.82
EPS / Growth 0.84

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 7.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 7.0% 7.0% 7.0%
Future PE 0.01 15.59 15.59
Future EPS 1.66 1.66 1.66
Value Price
MOS %
0.00
-100.0%
6.39
-76.9%
6.39
-76.9%
MOS Price 0.00 3.19 3.19
IRT 16.96 16.96 16.96

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.